Direkt zum Inhalt
Merck

Prevention of contrast-induced nephropathy: the rational use of sodium bicarbonate.

Nephrology nursing journal : journal of the American Nephrology Nurses' Association (2007-09-26)
Reymond Barreto
ZUSAMMENFASSUNG

The incidence of contrast-induced nephropathy (CIN) is increasing due to the growing number of patients undergoing radiocontrast studies. CIN is associated with a mortality rate as high as 34%. The purpose of this article is to review the strategies for preventing CIN and explore the role of sodium bicarbonate in this setting. A review of current literature suggests that prophylactic N-acetylcysteine and hydration with sodium bicarbonate may be the best pharmacological approach to preventing CIN. This article provides the dosing, administration, and monitoring guidelines for sodium bicarbonate, as well as implications for the nephrology nurse.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Natriumbicarbonat, ACS reagent, ≥99.7%
Sigma-Aldrich
Natriumbicarbonat, powder, BioReagent, Molecular Biology, suitable for cell culture, suitable for insect cell culture
Sigma-Aldrich
Natriumbicarbonat, ReagentPlus®, ≥99.5%, powder
Sigma-Aldrich
Natriumbicarbonat -Lösung, solution (7.5%), sterile-filtered, BioReagent, suitable for cell culture
Sigma-Aldrich
Natriumbicarbonat, puriss., meets analytical specification of Ph. Eur., BP, USP, FCC, E500, 99.0-100.5%, powder
Sigma-Aldrich
Natriumbicarbonat, BioXtra, 99.5-100.5%
USP
Natriumbicarbonat, United States Pharmacopeia (USP) Reference Standard
Supelco
Natriumbicarbonat-Konzentrat, 0.1 M NaHCO3 in water, eluent concentrate for IC
Sigma-Aldrich
Natriumbicarbonat, anhydrous, free-flowing, Redi-Dri, ReagentPlus®, ≥99.5%
Sigma-Aldrich
Natriumbicarbonat, −40-+140 mesh, ≥95%
Sigma-Aldrich
Natriumbicarbonat, tested according to Ph. Eur.
Sigma-Aldrich
Natriumbicarbonat-12C, 13C-depleted, 99.9 atom % 12C